Call For Investment In Prevention Of 'Neglected Diseases' To Improve Global HealthJuly 21, 2004The author of a Viewpoint article in this week's issue of THE LANCET argues for a renewed public-health effort to tackle so-called 'neglected diseases' which continue to have serious impact in less-developed countries. David Molyneux (Liverpool School of Tropical Medicine, UK) outlines how priorities on dealing with 'the big 3' infectious diseases-HIV/AIDS, TB, and malaria-is obstructing public-health initiatives to tackle preventable diseases such as the viral, bacterial, and parasitic infections of the tropics, and acute respiratory infections and diarrhoeal diseases of children. Examples are given of numerous cost-effective treatment programmes for diseases such as onchocerciasis (river blindness) and Chagas' disease. Professor Molyneux comments: "The emphasis on the big three killers and the derogatory assignment to the category of "other diseases" of those that can so easily be controlled or even eliminated neglects the proven success of a range of interventions. An investment of a fraction of the annual requirements of the Global Fund would bring long lasting benefit to the millions that still remain disabled, reduce morbidity, and prevent disablement in future generationsIf we are to ensure the efficient use of the substantial resources needed to reduce morbidity and mortality associated with HIV/AIDS, tuberculosis, and malaria, then a small investment in proven, cost-effective interventions against "other diseases"-preferably from the Global Fund resources-will bring sustainable public-health benefits, integrate well with and strengthen the health system, reduce disabling conditions, and bring collateral benefits to the health of the poorest nations". He concludes: "Policy makers are ignoring scientific and operational evidence that interventions against "other diseases" are effective. By concentrating on so few agents, current policies could perpetuate inequity, disrupt health financing policies, divert human resources from achievable goals, and deny opportunities for impoverished health systems to improve. Current policy also raises ethical issues. Resources are being transferred to interventions against the big three that, realistically, have only a limited chance of success as they are reactive and do not adequately control transmission-a pre-requisite for any public-health impact". Contact: Professor David H Molyneux, Lymphatic Filiariasis Support Centre, Liverpool School of Tropical Medicine, Pembroke Place, LIVERPOOL L3 5QA, UK; T) +44 (0)151 705 3145 or +44 (0)7780 991824; E) fahy@liv.ac.uk Eileen Taylor, Liverpool School of Tropical Medicine Press Officer; T) +44 (0)7786 613604; E) etay@waitrose.com | |||||||||||||||||||||
Science Research Departments
Earth Science Alternative Energy | Anthropology and Archaeology | Earthquakes and Volcanoes | Environment and Nature News | Global Warming | High-Energy and Particle Physics | Ozone Hole | Scientists Slow Light | Tsunami Space Science Astronomy and Space News | Black Holes | Chandra X-Ray Observatory | Extrasolar Planets | Hubble Telescope | International Space Station | Jupiter Galileo Mission | Jupiter Cassini Mission Flyby | Mars Exploration | Mars Odyssey 2001 | Mars Global Surveyor | Mars Polar Lander | Mars Climate Orbiter | Mars Pathfinder | Meteors and Asteroids | Mir Space Station | NEAR Asteroid Probe Mission | Pluto Planet Debate | Search for Extraterrestrial Life | Space Shuttle Program | Space Shuttle Mission: STS-102 | Space Weather Life Science Animal News | Biotechnology and Genetics | Brain Research | Human Cloning | Dinosaur and Fossil Discoveries | Endangered Species | Gene Therapy | Genetically Modified Food | Stem Cell Research | Whales and Whaling |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||